Jie Lv

机构：North China University of Science and Technology, Peking University, Peking University Cancer Hospital, People’s Hospital of Rizhao, North China University of Science and Technology Affiliated Hospital, Beijing Municipal Education Commission · ORCID：0000-0001-8655-4992

发表论文 86 篇 · 总被引 589 次 · h-index 12

代表论文

• Covalent organic frameworks-derived carbon nanospheres based nanoplatform for tumor specific synergistic therapy via oxidative stress amplification and calcium overload (2024 · Journal of Colloid and Interface Science · 被引 25)
• Targeting Fibroblast Activation Protein for Molecular Imaging of Fibrotic Remodeling in Pulmonary Arterial Hypertension (2025 · Journal of Nuclear Medicine · 被引 13)
• Proteomic characterization of esophageal squamous cell carcinoma response to immunotherapy reveals potential therapeutic strategy and predictive biomarkers (2024 · Journal of Hematology & Oncology · 被引 9)
• First-in-human study of PSMA-targeting agent, [18F]AlF-P16-093: dosimetry and initial evaluation in prostate cancer patients (2024 · European Journal of Nuclear Medicine and Molecular Imaging · 被引 9)
• Axillary management in patients with clinical node-negative early breast cancer and positive sentinel lymph node: a systematic review and meta-analysis (2024 · Frontiers in Oncology · 被引 9)
• Advances in B Cell Targeting for Treating Muscle-Specific Tyrosine Kinase-Associated Myasthenia Gravis (2024 · ImmunoTargets and Therapy · 被引 6)